Latest updates for Cancer Drugs

Fresh curated links around cancer drugs are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Cancer Drug Shortage Renews Calls For Federal Action
  • Shape-Shifting Drug Supercharges Cancer Treatment in Mice
  • New Drug Candidate Helps Overcome Cancer Treatment Resistance

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

drugs.com /1 month ago

Cancer Drug Shortage Renews Calls For Federal Action

FRIDAY, June 26, 2026 — Cancer doctors across the United States are running short of essential generic chemotherapy drugs, and some fear the squeeze could force widespread rationin...

Read source
scitechdaily.com /3 weeks ago

Shape-Shifting Drug Supercharges Cancer Treatment in Mice

A shape-changing drug attacks tumors in several ways and improves outcomes in mice. A tumor is rarely made up of identical cells. As cancer progresses or adapts to treatment, diffe...

Read source
scitechdaily.com /1 week ago

New Drug Candidate Helps Overcome Cancer Treatment Resistance

An experimental drug called CS18 weakened several cancer survival mechanisms and helped overcome treatment resistance in laboratory and animal studies. Cancer treatments can work a...

Read source
greaterkashmir.com /4 days ago

A smart cancer drug activating primarily in cancer cells could replace chemotherapy

New Delhi, Aug 19: A new "smart" cancer drug designed to switch on and work only inside cancer cells can replace traditional chemotherapy, which in many cases also harms healthy ce...

Read source
bbc.co.uk /2 weeks ago

Dewormer and scabies drugs being sold as cancer treatments, BBC investigation finds

A terminally-ill man was offered the drugs by a stair lift salesman claiming they could shrink tumours.

Read source
taipeitimes.com /3 days ago

MRNA cancer drug shows success in curbing melanoma

Read source
thenational.scot /1 month ago

New cancer drugs approved for use by NHS in Scotland

New cancer treatments have been approved for use by the NHS in Scotland

Read source
biopharmadive.com /1 month ago

Merck ADC, in China study, shows potential to replace chemo in lung cancer

The results were seen by Wall Street analysts as “direct proof-of-concept” that sac-TMT, a drug Merck views as a “cornerstone,” could be part of a future treatment standard for fro...

Read source
bioengineer.org /1 month ago

A Common Heart Medication Reveals Unexpected Potential as a Cancer Fighter — Scientists Uncover the Mechanism

A Well-Known Heart Medication Emerges as a Surprising Ally in Cancer Therapy: Unraveling the Mechanism Behind Dobutamine’s Anticancer Potential Dobutamine, a drug classically utili...

Read source
independent.co.uk /2 weeks ago

Drugs for common eye condition could be used to treat cancer, experts say

Scientists at The Institute for Cancer Research say repurposing drugs could mean they reach patients faster

Read source
bioengineer.org /1 month ago

Multi-metal cooperation drives lung cancer chemoresistance, reversed by MiADMSA

In the unending war against cancer, few adversaries have proven as stubbornly resilient as chemoresistance in lung malignancies. For decades, oncologists have watched with frustrat...

Read source
bioengineer.org /1 week ago

Locking therapeutic strategy could make cancer treatment more precise

Although modern cancer treatments can eliminate malignant cells with remarkable efficiency, their lack of perfect selectivity often exposes healthy tissues to the same molecular as...

Read source
bioengineer.org /2 days ago

Imaging shows how a tumor-fighting drug causes cellular breakdown

Cancer drugs are designed to attack the molecular machinery that allows tumors to grow, divide, and spread. Yet once a drug enters a living cell, its effects may extend far beyond...

Read source
biopharmadive.com /1 week ago

New Taiho, Cullinan data heats up lung cancer drug battle

The findings position their drug, zipalertinib, as a threat to multiple approved medicines — while setting a bar for others in testing.

Read source
bioengineer.org /1 month ago

KRAS Drugs Offer New Hope for Rare Appendix Cancer Treatment

In a groundbreaking development for appendix cancer treatment, researchers at The University of Texas MD Anderson Cancer Center have unveiled promising results targeting the mutant...

Read source
biopharmadive.com /1 month ago

Cancer, immune drugmakers dominate VC funding so far in 2026

Drug developers focusing on either disease area made up more than 40% of the number of biotech companies and amount raised so far in 2026, per BioPharma Dive data.

Read source
thehindubusinessline.com /1 month ago

Lilly launches cancer therapy Tanstrive for patients with advanced or metastatic solid tumors with a RET gene alteration

Twice a day oral drug is priced at ₹2.15 lakh for two weeks treatment

Read source
icij.org /2 weeks ago

After cancer drug counterfeiting scandal, India imposes new tracing requirements

Reporting by ICIJ and The Indian Express illustrated how Indian counterfeiters exploited the high price of the lifesaving cancer drug Keytruda and the desperation of patients seeki...

Read source
medcitynews.com /1 month ago

With New Phase 3 Data, Roche Claims an Edge Over Amgen and BMS Lung Cancer Drugs

Roche’s divarasib was designed offer greater potency and selectivity to KRAS G12C compared to first-generation drugs in this class marketed by Amgen and Bristol Myers Squibb. The S...

Read source
medcitynews.com /2 weeks ago

Pathos Picks Up Two Cancer Drugs Poised for Clinical Development With AI Agents

Pathos AI struck a deal for rights to a bispecific antibody drug conjugate from Alphamab that could become first in a new class of cancer drugs. Separately, the startup began a par...

Read source
aacr.org /1 month ago

FDA Approvals in Oncology: April-June 2026 

During the second quarter of 2026, oncology approvals issued by the U.S. Food and Drug Administration expanded the treatment options available for patients with breast cancer, urin...

Read source
medcitynews.com /1 month ago

A $1B Acquisition Gives Novartis a Way to Stand Out in Crowded Area of Cancer

Myricx Bio brings to Novartis antibody drug conjugates with a novel cancer-killing payload called an NMT inhibitor. Novartis says Myricx’s drugs could have advantages over currentl...

Read source
aacr.org /1 week ago

Smart Chemotherapy Gets Smarter: Advances in Antibody-drug Conjugates

Antibody-drug conjugates, or ADCs, have emerged as a significant class of cancer therapies over the past two decades. New research has helped to revolutionize the drug class and de...

Read source
drugs.com /3 days ago

Personalized Vaccine Helped Melanoma Patients Stay Cancer-Free Longer, Drugmakers Say

THURSDAY, Aug. 20, 2026 — An experimental vaccine kept melanoma from returning or spreading in people at high risk of the skin cancer coming back, drugmakers Moderna and Merck anno...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Cancer Drugs

feeds.bbci.co.uk

Recent coverage from public sources
Public source

feeds.feedburner.com

Recent coverage from public sources
Public source

independent.co.uk

Recent coverage from public sources
Public source

bioengineer.org

Recent coverage from public sources
Public source

medcitynews.com

Recent coverage from public sources
Public source

aacr.org

Recent coverage from public sources
Public source